NGNE icon

Neurogene

22 hedge funds and large institutions have $31.2M invested in Neurogene in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 1 closing their positions.

Holders
22
Holders Change
Holders Change %
0%
% of All Funds
0.59%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
5
Reduced
8
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
BBA
1
Baker Bros. Advisors
New York
$9.08M 1,210,350 -1,501 -0.1%
Franklin Resources
2
Franklin Resources
California
$4.42M 588,945 -22,550 -4%
BC
3
Broadfin Capital
New York
$3.99M 531,768 +21,268 +4%
VAM
4
Visium Asset Management
New York
$2.62M 349,300 +50,496 +17%
CAM
5
Cormorant Asset Management
Massachusetts
$2.25M 300,000
DCM
6
Driehaus Capital Management
Illinois
$1.87M 249,345 -90,236 -27%
HCMT
7
Highland Capital Management (Texas)
Texas
$1.18M 157,000 -19,247 -11%
RA
8
Royce & Associates
New York
$978K 130,454 +46,722 +56%
PA
9
Perceptive Advisors
New York
$975K 130,000
PI
10
Putnam Investments
Massachusetts
$864K 115,156
BA
11
BlackRock Advisors
Delaware
$854K 113,800 -400 -0.4%
Alyeska Investment Group
12
Alyeska Investment Group
Illinois
$764K 101,873 -3,773 -4%
Deutsche Bank
13
Deutsche Bank
Germany
$517K 69,079 +50,214 +266%
BG
14
BlackRock Group
United Kingdom
$366K 48,800
BlackRock
15
BlackRock
New York
$181K 24,100
Geode Capital Management
16
Geode Capital Management
Massachusetts
$120K 16,116
SCM
17
Sterling Capital Management
North Carolina
$97K 13,000 -1,718 -12%
SIM
18
Spark Investment Management
New York
$86K 11,500 +11,500 New
BIT
19
BlackRock Institutional Trust
California
$20K 2,666
Citigroup
20
Citigroup
New York
$11K 1,500 +1,000 +200%
TRCT
21
Tower Research Capital (TRC)
New York
$8K 1,044 -973 -48%
Jane Street
22
Jane Street
New York
-20,000 Closed
Morgan Stanley
23
Morgan Stanley
New York
$0 18 +18 New